arginyl-glycyl-aspartic acid has been researched along with EHS Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashton, JR; Badea, CT; Castle, KD; Kirsch, DG; Qi, Y; West, JL | 1 |
| Kanamori, M; Matsui, H; Ohmori, K; Tsuji, H; Yudoh, K | 1 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and EHS Tumor
| Article | Year |
|---|---|
Dual-Energy CT Imaging of Tumor Liposome Delivery After Gold Nanoparticle-Augmented Radiation Therapy.
Topics: Animals; Antineoplastic Agents; Blood Vessels; Doxorubicin; Gold; Iodine; Liposomes; Metal Nanoparticles; Mice; Oligopeptides; Permeability; Sarcoma; Sarcoma, Experimental; Tomography, X-Ray Computed; Treatment Outcome | 2018 |
Tumor cell attachment to laminin promotes degradation of the extracellular matrix and cell migration in high-metastatic clone cells of RCT sarcoma in vitro.
Topics: Amino Acid Sequence; Animals; Cell Adhesion; Cell Movement; Clone Cells; Collagen; Drug Combinations; Extracellular Matrix; Fibronectins; Kinetics; Laminin; Mice; Mice, Inbred C3H; Oligopeptides; Proteoglycans; Sarcoma, Experimental; Tumor Cells, Cultured | 1995 |